Get the app!
Back to Trades
Sell4

Denali Therapeutics Inc.

DNLI

Total Value
$8.5M
Sales
$7.4M
1 transaction

Company Information

Ticker Symbol
DNLI
CIK
0001714899

Insider Information

Role
President and CEO, Director
Location
SOUTH SAN FRANCISCO, CA

Filing Details

Filing Date
Jul 11, 2025
Transaction Date
Jul 9, 2025
Accession Number
0001714899-25-000149
Form Type
4

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.